Scientists at the Leibniz Institute DSMZ in Germany developed a novel panel of 100 blood cancer cell lines for use in basic research and development of targeted therapies. They used GENEWIZ’s whole exome sequencing service to characterize the cell lines and identify potential oncogenes therein.
Researchers from the Pasteur Institute in France have discovered a crucial immune reaction in babies during weaning that prevents inflammatory disorders later in life. The new study used RNA-Seq conducted by GENEWIZ to profile the gut transcriptome during the transition to solid foods
Rutgers scientists have revealed a key signaling pathway for cell differentiation in the intestinal lining. The new study published in Nature Genetics used GENEWIZ’s Single-Cell RNA-Seq service.